RenovoRx, Inc.
RNXT
$0.87
$0.022.89%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 928.00K | 662.00K | 240.00K | 43.00K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 928.00K | 662.00K | 240.00K | 43.00K | -- |
| Cost of Revenue | 299.00K | 246.00K | 94.00K | -- | -- |
| Gross Profit | 629.00K | 416.00K | 146.00K | 43.00K | -- |
| SG&A Expenses | 5.92M | 5.37M | 5.34M | 4.99M | 4.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.55M | 11.91M | 11.84M | 11.01M | 10.12M |
| Operating Income | -11.62M | -11.25M | -11.60M | -10.97M | -10.12M |
| Income Before Tax | -11.11M | -10.66M | -10.16M | -8.81M | -9.16M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.11 | -10.66 | -10.16 | -8.81 | -9.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.11M | -10.66M | -10.16M | -8.81M | -9.16M |
| EBIT | -11.62M | -11.25M | -11.60M | -10.97M | -10.12M |
| EBITDA | -8.99M | -5.79M | -3.11M | -- | -1.78M |
| EPS Basic | -0.35 | -0.37 | -0.39 | -0.39 | -0.57 |
| Normalized Basic EPS | -0.22 | -0.23 | -0.24 | -0.24 | -0.36 |
| EPS Diluted | -0.35 | -0.37 | -0.39 | -0.39 | -0.57 |
| Normalized Diluted EPS | -0.22 | -0.23 | -0.24 | -0.24 | -0.36 |
| Average Basic Shares Outstanding | 129.73M | 118.02M | 105.49M | 89.04M | 74.64M |
| Average Diluted Shares Outstanding | 129.73M | 118.02M | 105.49M | 89.04M | 74.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |